These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8723173)

  • 1. Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril.
    Schwartz D; Kornowski R; Schwartz IF; Dotan I; Weinreb B; Averbuch M; Golan Y; Levo Y; Iaina A
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):75-9. PubMed ID: 8723173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure.
    McElnay JC; al-Furaih TA; Hughes CM; Scott MG; Nicholls DP
    Eur J Clin Pharmacol; 1996; 49(6):471-6. PubMed ID: 8706772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
    Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
    J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on renal function in patients with congestive heart failure.
    Pierpont GL; Francis GS; Cohn JN
    Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal effects of captopril in patients with congestive heart failure.
    Ribstein J; Mimran A
    J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
    Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
    Jansson K; Dahlström U; Karlberg BE; Karlsson E; Nylander E; Nyquist O; Karlberg KE
    J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.
    Schwartz D; Kornowski R; Lehrman H; Averbuch M; Pines A; Greenland M; Finkelstein A; Levo Y
    Cardiology; 1992; 81(6):334-9. PubMed ID: 1304414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for congenital renovascular hypoplasia and renal artery stenosis by acute converting enzyme inhibition.
    Cottone S; Mercadante G; Contorno A; Giuntini G; Mangano MT; Rabiolo A; Cerasola G
    Nephron; 1993; 63(1):54-7. PubMed ID: 8446252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril on cardiorenal hemodynamics in patients with severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Exp Hypertens A; 1987; 9(2-3):575-81. PubMed ID: 3038420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Medina N; Yushak M; Gottlieb SS
    J Am Coll Cardiol; 1987 Oct; 10(4):837-44. PubMed ID: 2821091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.